Becton, Dickinson and Company (BDX)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for BDX is $179.89, 6.2% below the last close of $191.75 on Oct 16, 2026; targets range from $159.95 to $208.96. Rating consensus: Hold.
Snapshot
- P/E57.8x
- P/E vs sector+105.1%
- P/E vs own+70.5%
- Target upside-6.2%
- ConsensusHold
- Market cap$52.23B
- FCF yield+5.0%
- Insiders-$1.27M
- Earnings in20d
- News0.00
Why it moved
Becton, Dickinson and Company (BDX) fell 1.0% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
0 stories on the day (30-day average 0.8).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $191.75 · +34.9% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50Death 4d ago
- RSI64
- Support-3.6%
- Resistance—
- Off 52w high-1.0%
- Off ATH-8.0%
- 52w range$191.75
- Bollingerupper half
- MACD1.20
- ATR+2.2%
- Volume0.9x
Analyst price targets
9 firms with a target in the last 12 months · last close $191.75 · as of Oct 16, 2026
Strong buy 1 · Buy 6 · Hold 7 · Sell 0 · Strong sell 1
Revenue and free cash flow
Q3 FY2026: Revenue -9.5% year over year, free cash flow 10.2% of revenue, operating margin 13.3%.
| Q3 FY2026 | Jun 30, 2026 | $4.98B | 1.37 | $509M | 46.5% | 13.3% | 7.6% |
| Q2 FY2026 | Mar 31, 2026 | $4.71B | -1.11 | $546M | 45.7% | 2.0% | -6.6% |
| Q1 FY2026 | Dec 31, 2025 | $5.25B | 1.34 | $549M | 44.6% | 11.3% | 7.3% |
| Q4 FY2025 | Sep 30, 2025 | $5.89B | 1.72 | $1B | 47.5% | 11.8% | 8.4% |
| Q3 FY2025 | Jun 30, 2025 | $5.51B | 2.00 | $1.04B | 47.8% | 16.0% | 10.4% |
| Q2 FY2025 | Mar 31, 2025 | $5.27B | 1.07 | $35M | 42.8% | 10.4% | 5.8% |
| Q1 FY2025 | Dec 31, 2024 | $5.17B | 1.04 | $588M | 43.2% | 8.8% | 5.9% |
| Q4 FY2024 | Sep 30, 2024 | $5.44B | 1.45 | $882M | 45.7% | 11.4% | 7.4% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $426.70 | -0.3% | -28.0% | +12.1% | 48.5 | $151B | |
| 2 | | $191.75 | -1.0% | -1.0% | -6.2% | 57.8 | $52.23B | |
| 3 |  | $86.60 | -1.7% | -9.0% | +15.2% | 49.8 | $49.9B | |
| 4 |  | $238.97 | -1.3% | -12.7% | +3.7% | 23.0 | $33.61B | |
| 5 |  | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | |
| 6 |  | $85.81 | -2.3% | -7.2% | +3.6% | 10.5 | $14.61B | |
| 7 |  | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | |
| 8 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.